Plerixafor Solution
Product Images NDC 43598-308

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 43598-308). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton (Carton)

Packaging label for Plerixafor Injection 24 mg/1.2 mL (20 mg/mL) solution for subcutaneous injection by Dr. Reddy's Laboratories Inc. The label includes dosage details, storage instructions, NDC 43598-308-23, and distributor information. It features a barcode and specifies that one single-dose vial is included, with unused portions to be discarded.*

FDA Label Image

Structure (Structure)

Chemical structure of Plerixafor, a molecule featuring two macrocyclic ring systems connected by a benzene ring, depicted as a structural formula diagram.*

FDA Label Image

Vial (Vial)

Label for Plerixafor Injection, 24 mg/1.2 mL (20 mg/mL) solution for subcutaneous injection. This single-dose vial is distributed by Dr. Reddy's Laboratories Inc., Princeton, NJ, and made in India. The label also includes the NDC 43598-308-23 barcode and usage instructions to discard unused portions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.